Evaluating Cardiovascular Phenotypes Using Induced Pluripotent Stem Cells

Enrolling by invitationOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2030

Conditions
Coronary Artery Disease
Trial Locations (1)

92037

Scripps Translational Science Institute, La Jolla

All Listed Sponsors
lead

Scripps Translational Science Institute

OTHER